Clinical Trials in Mexico / NCT04817969
Active, not recruiting
Not applicable
Persona Ti-Nidium Post-Market Clinical Follow-up
NCT04817969 · tracked via the Priya Life Science Mexico tracker
Condition(s) studied
Knee Pain ChronicOsteoarthritisRheumatoid ArthritisTraumatic ArthritisPolyarthritisVarus DeformityValgus DeformityFlexion Deformity of the KneeAvascular NecrosisPatellofemoral Osteoarthritis
Investigational drug(s) / intervention(s)
Zimmer Biomet Persona Ti-Nidium Total Knee System
Zimmer Biomet Persona Ti-Nidium Total Knee System: Primary Knee Total Arthroplasty
Study summary
The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.
Eligibility
Inclusion Criteria:
1. Patient is of legal age and skeletally mature
2. Patient is willing and able to provide written Informed Consent by signing and dating the IRB-approved Informed Consent document
3. Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
4. Patient qualifies for total knee arthroplasty based upon physical exam and medical history, and meets the approved indications for use of the Persona Ti-Nidium Knee System and Vivacit-E polyethylene articulating surface
5. Independent of study participation, patient is a candidate for the commercially available Persona Ti-Nidium Knee and Vivacit-E polyethylene articulating surface, implanted in accordance with product labeling
Study Device Inclusion Criteria:
The Persona Ti-Nidium Total Knee is intended for patients with severe pain and disability due to the following:
1. Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
2. Collagen disorders, and/or avascular necrosis of the femoral condyle.
3. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy.
4. Moderate valgus, varus, or flexion deformities.
Exclusion Criteria:
1. Patient is unwilling to sign the Informed Consent
2. Patient is currently participating in any other surgical intervention or pain management study
3. Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)
4. Patient has a mental or neurologic condition who is unwilling or incapable of following postoperative care instructions
5. Patient has a condition which would, in the judgement of the Investigator, place the patient at undue risk or interfere with the conduct of the study
6. Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation
Study Device Exclusion Criteria
1. Previous history of infection in the affected joint and/or other local/systematic infection that may affect the prosthetic joint
2. Insufficient bone stock on femoral or tibial surfaces
3. Skeletal immaturity
4. Neuropathic arthropathy
5. Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb
6. A stable, painless arthrodesis in a satisfactory functional position
7. Severe instability secondary to the absence of collateral ligament integrity
8. Rheumatoid arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
9. The kinematic alignment surgical technique is contraindicated for patients with greater than 5° valgus deformity with medial collateral ligament (MCL) insufficiency
Primary outcome measure(s)
- Oxford Knee Score (OKS) — 10 years
A patient reported functional outcome score for knee arthroplasty. This score ranges from 0-48, with higher scores indicating a better outcome.
Trial sites (7)
| Facility | City | Region | Status |
|---|---|---|---|
| Denver Hip & Knee, Inc. | Parker | Colorado | |
| MedStar Health Research Institute | Hyattsville | Maryland | |
| Mississippi Sports Medicine and Orthopaedic Center | Jackson | Mississippi | |
| New Mexico Orthopaedic Associates | Albuquerque | New Mexico | |
| Duke University | Durham | North Carolina | |
| Rothman Orthopaedic Institute | Philadelphia | Pennsylvania | |
| Monument Health Rapid City Hospital, Inc. | Rapid City | South Dakota |
More Zimmer Biomet trials in Mexico
Prospective G7 Dual Mobility Total Hip PMCF
Active, not recruiting
Persona Partial Knee Clinical Outcomes Study
Active, not recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Active, not recruiting
Other trials for the same condition
"Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis"
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04817969 on ClinicalTrials.gov ↗ ← All trials in Mexico